Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwin N Ananthakrishnan

Showing results (61-70 of 418) with videos related to

Pageof 42
Sort By:
Inflammatory Bowel Diseases|December 20, 2011
Vitamin D and IBD: more pieces to the puzzle, still no complete picturePunyanganie De Silva, Ashwin N Ananthakrishnan
Gastroenterology|December 3, 2014
The Holy Grail, or only half way there?Ashwin N Ananthakrishnan, Stephen B Hanauer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysisNienke Z Borren, Ashwin N Ananthakrishnan
The American Journal of Gastroenterology|July 8, 2010
Editorial: improved efficacy of biological maintenance therapy in "early" compared with "late" Crohn's disease: strike while the iron is hot with anti-TNF agents?Ashwin N Ananthakrishnan, David G Binion
Gastroenterology|March 1, 2014
Reply: To PMID 23912083Ashwin N Ananthakrishnan, Andrew T Chan
Inflammatory Bowel Diseases|October 15, 2009
Clostridium difficile and inflammatory bowel disease: more questions than answers?Ashwin N Ananthakrishnan, David G Binion
Expert Review of Gastroenterology & Hepatology|October 12, 2010
Impact of Clostridium difficile on inflammatory bowel diseaseAshwin N Ananthakrishnan, David G Binion
Inflammatory Bowel Diseases|May 21, 2020
Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic EsophagitisMichael J Mintz, Ashwin N Ananthakrishnan
The American Journal of Gastroenterology|April 15, 2020
Clinical Research and Trials-A "Nonessential" Victim of the COVID-19 Pandemic?Laurent Peyrin-Biroulet, Ashwin N Ananthakrishnan
Gastroenterology|March 26, 2015
The Toronto consensus guidelines for nonhospitalized ulcerative colitis: a welcome update but not the end of the storyAshwin N Ananthakrishnan, Sunanda V Kane
Pageof 42

Showing results (61-70 of 418) with videos related to

Sort By:
Pageof 42
Inflammatory Bowel Diseases|December 20, 2011
Vitamin D and IBD: more pieces to the puzzle, still no complete picturePunyanganie De Silva, Ashwin N Ananthakrishnan
Gastroenterology|December 3, 2014
The Holy Grail, or only half way there?Ashwin N Ananthakrishnan, Stephen B Hanauer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysisNienke Z Borren, Ashwin N Ananthakrishnan
The American Journal of Gastroenterology|July 8, 2010
Editorial: improved efficacy of biological maintenance therapy in "early" compared with "late" Crohn's disease: strike while the iron is hot with anti-TNF agents?Ashwin N Ananthakrishnan, David G Binion
Gastroenterology|March 1, 2014
Reply: To PMID 23912083Ashwin N Ananthakrishnan, Andrew T Chan
Inflammatory Bowel Diseases|October 15, 2009
Clostridium difficile and inflammatory bowel disease: more questions than answers?Ashwin N Ananthakrishnan, David G Binion
Expert Review of Gastroenterology & Hepatology|October 12, 2010
Impact of Clostridium difficile on inflammatory bowel diseaseAshwin N Ananthakrishnan, David G Binion
Inflammatory Bowel Diseases|May 21, 2020
Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic EsophagitisMichael J Mintz, Ashwin N Ananthakrishnan
The American Journal of Gastroenterology|April 15, 2020
Clinical Research and Trials-A "Nonessential" Victim of the COVID-19 Pandemic?Laurent Peyrin-Biroulet, Ashwin N Ananthakrishnan
Gastroenterology|March 26, 2015
The Toronto consensus guidelines for nonhospitalized ulcerative colitis: a welcome update but not the end of the storyAshwin N Ananthakrishnan, Sunanda V Kane
Pageof 42